Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SENS
SellHot AirSenseonics Holdings, Inc. · Healthcare · United States · $493M · Avg Vol: $7M/d
COMPANY DESCRIPTION
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.4M | 22.4M | 22.5M | 35.3M | 29.1% | 48.5M | 64.2M | 97.9M | 66.7% |
| EPS | 2.76 | -1.12 | -28.51 | -1.66 | — | -2.24 | -2.29 | -1.95 | — |
| Shares | 52.2M | 52.2M | 52.2M | 41.3M | -21.0% | 52.9M | — | — | — |
| Debt | 75.4M | 47.8M | 61.1M | 41.4M | -18.1% | 62.8M | — | — | — |
| Equity | -2.6M | 35.8M | -16.6M | 61.0M | 30.6% | — | — | — | — |
| Op CF | -66.3M | -70.2M | -60.5M | -59.1M | — | -95.9M | — | — | — |
| Inv CF | 26.9M | 89.7M | 32.8M | -53.4M | — | — | — | — | — |
| Fin CF | 41.8M | 20.4M | 26.8M | 78.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SENS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SENS | Senseonics Holdings, Inc.(you) | $493M | 29 | Sell |
| NPCE | NeuroPace, Inc. | $495M | 32 | Sell |
| OFIX | Orthofix Medical Inc. | $392M | 27 | Sell |
| CTKB | Cytek Biosciences, Inc. | $608M | 32 | Sell |
| CERS | Cerus Corporation | $534M | 37 | Hold |
| BBNX | Beta Bionics, Inc. | $887M | 27 | Sell |
| CBLL | CeriBell, Inc. | $911M | 27 | Sell |
| QDEL | QuidelOrtho Corporation | $1.0B | 29 | Sell |
| PACB | Pacific Biosciences of California, Inc. | $435M | 16 | Strong Sell |
| SGHT | Sight Sciences, Inc. | $471M | 44 | Hold |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%